Literature DB >> 9133670

Nuclear domains of the RNA subunit of RNase P.

M R Jacobson1, L G Cao, K Taneja, R H Singer, Y L Wang, T Pederson.   

Abstract

The ribonucleoprotein enzyme RNase P catalyzes the 5' processing of pre-transfer RNA, and has also recently been implicated in pre-ribosomal RNA processing. In the present investigation, in situ hybridization revealed that RNase P RNA is present throughout the nucleus of mammalian cells. However, rhodamine-labeled human RNase P RNA microinjected into the nucleus of rat kidney (NRK) epithelial cells or human (HeLa) cells initially localized in nucleoli, and subsequently became more evenly distributed throughout the nucleus, similar to the steadystate distribution of endogenous RNase P RNA. Parallel microinjection and immunocytochemical experiments revealed that initially nucleus-microinjected RNase P RNA localized specifically in the dense fibrillar component of the nucleolus, the site of pre-rRNA processing. A mutant RNase P RNA lacking the To antigen binding domain (nucleotides 25-75) did not localize in nucleoli after nuclear microinjection. In contrast, a truncated RNase P RNA containing the To binding domain but lacking nucleotides 89-341 became rapidly localized in nucleoli following nuclear microinjection. However, unlike the full-length RNase P RNA, this 3' truncated RNA remained stably associated with the nucleoli and did not translocate to the nucleoplasm. These results suggest a nucleolar phase in the maturation, ribonucleoprotein assembly or function of RNase P RNA, mediated at least in part by the nucleolar To antigen. These and other recent findings raise the intriguing possibility of a bifunctional role of RNase P in the nucleus: catalyzing pre-ribosomal RNA processing in the nucleolus and pre-transfer RNA processing in the nucleoplasm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133670     DOI: 10.1242/jcs.110.7.829

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  60 in total

1.  Box H and box ACA are nucleolar localization elements of U17 small nucleolar RNA.

Authors:  T S Lange; M Ezrokhi; F Amaldi; S A Gerbi
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

Review 2.  Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function.

Authors:  R J Maraia; R V Intine
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 3.  Survey and summary: transcription by RNA polymerases I and III.

Authors:  M R Paule; R J White
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

4.  Signal recognition particle components in the nucleolus.

Authors:  J C Politz; S Yarovoi; S M Kilroy; K Gowda; C Zwieb; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Prespliceosomal assembly on microinjected precursor mRNA takes place in nuclear speckles.

Authors:  I Melcák; S Melcáková; V Kopský; J Vecerová; I Raska
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

Review 6.  Eukaryotic ribonuclease P: increased complexity to cope with the nuclear pre-tRNA pathway.

Authors:  S Xiao; F Houser-Scott; D R Engelke
Journal:  J Cell Physiol       Date:  2001-04       Impact factor: 6.384

Review 7.  Fluorescent RNA cytochemistry: tracking gene transcripts in living cells.

Authors:  T Pederson
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

8.  RNA-protein interactions in the human RNase MRP ribonucleoprotein complex.

Authors:  H Pluk; H van Eenennaam; S A Rutjes; G J Pruijn; W J van Venrooij
Journal:  RNA       Date:  1999-04       Impact factor: 4.942

Review 9.  La protein and its associated small nuclear and nucleolar precursor RNAs.

Authors:  Richard J Maraia; Robert V Intine
Journal:  Gene Expr       Date:  2002

10.  Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.

Authors:  Gunter Kraus; Rebeca Geffin; Gina Spruill; Andrea K Young; Rachel Seivright; Diana Cardona; Jennifer Burzawa; H James Hnatyszyn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.